Mostrar registro simples

dc.contributor.authorBorgoño, José Manueles_ES
dc.contributor.authorGreiber, Rosaes_ES
dc.contributor.authorHeras, Elsaes_ES
dc.contributor.authorCarrillo, Bes_ES
dc.contributor.authorSolari, Ges_ES
dc.contributor.authorConcha, Fes_ES
dc.date.accessioned2015
dc.date.available2015
dc.date.issueds.d.es_ES
dc.date.issued1971es_ES
dc.identifier.urihttps://iris.paho.org/handle/10665.2/15253
dc.description.abstractReactions to combined attenuvax-smallpox vaccine were studied, and were compared with those produced by each type of vaccine separately, in children from one to five years of age, controlled by maternal-child care centers under the National Health Service in Santiago, Chile. Combined freeze-dried and preblended attenuvax-smallpox vaccine and freeze-dried "Dryvax" smallpox vaccine were used. The combined vaccine was jet-injected, while the measles vaccine was administered in the form of subcutaneous injections, and the smallpox vaccine by the multipuncture techniqueen_US
dc.description.abstractThe new preblended and combined attenuvax-smallpox vaccine administered by jet injection produces general clinical reactions similar to or milder than those caused by each vaccine when administered separatelyen_US
dc.description.abstract"Takes" were recorded in 96.9 per cent of children inoculated with the combined vaccine, which is an excellent resulten_US
dc.description.abstractTo judge from the rise in titers in serological tests counts for both viruses in the cases inoculated, there was no evidence of interference between antigens. The conversion rate for each virus closely resembled that obtained when each vaccine was administered separately, and the geometric mean of the hemoagglutination inhibition titers was also very similar for the combined vaccine and for each vaccine administered separatelyen_US
dc.description.abstractRevaccination against smallpox in children inoculated two months earlier with the ... (AU)en_US
dc.format.extentTabes_ES
dc.relation.ispartofseriesBoletín de la Oficina Sanitaria Panamericana (OSP);70(3),mar. 1971es_ES
dc.subjectVacina contra Sarampopt_BR
dc.subjectVacina contra Sarampopt_BR
dc.subjectVacina Antivariólicapt_BR
dc.subjectVacina Antivariólicapt_BR
dc.subjectDoenças Transmissíveispt_BR
dc.subjectReações Antígeno-Anticorpopt_BR
dc.subjectChilees_ES
dc.titleEvaluación de la vacuna combinada attenuvax-viruela en Chilees_ES
dc.title.alternativeEvaluation of combined attenuvax-smallpox vaccine in Chilees_ES
dc.typeJournal articlesen_US
dc.rights.holderPan American Health Organizationen_US


Arquivos deste item

Thumbnail

Este item aparece na(s) seguinte(s) coleção(s)

Mostrar registro simples